comparemela.com

Latest Breaking News On - Targeted radionuclide therapy - Page 8 : comparemela.com

ITM Isotope Technologies Munich SE: ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area

Grand Pharma has licensed the development, manufacturing and commercialization rights of ITM's Targeted Radionuclide Therapeutic candidates ITM-11 (n.c.a 177Lu-edotreotide) and ITM-41 (n.c.a 177Lu-zoledronate)

Hong kongValeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonFrank zhouGroup limitedCorporate communicationsTrophic communicationsGrand pharmaRadionuclide therapeuticGreater chinaTechnologies munichGrand pharmaceutical group limitedChief executive officerTargeted radionuclide therapy

ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area

Press release content from Business Wire. The AP news staff was not involved in its creation.

Hong kongValeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonFrank zhouContactcorporate communicationsGroup limitedCorporate communicationsTrophic communicationsMedia requeststrophic communicationsTechnologies munichGrand pharmaceutical group limitedChief executive officerGreater chinaTargeted radionuclide therapy

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions - read this article along with other careers information, tips and advice on BioSpace

Ji xingUnited statesNew zealandUnited kingdomBritish columbiaSan diegoMetrion biosciencesErik gatenholmSelective inhibitor of nuclear exportEngland avacta groupDrug administrationJi xing pharmaceuticalsCanadian ministry of innovationAssessment of spondyloarthritis international societyBioqube factory fundTechnology oganisation

Global Roundup: BICO Group Snaps up Biosero and its Software Solutions

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

Ji xingUnited statesNew zealandUnited kingdomBritish columbiaSan diegoMetrion biosciencesErik gatenholmSelective inhibitor of nuclear exportEngland avacta groupDrug administrationJi xing pharmaceuticalsCanadian ministry of innovationAssessment of spondyloarthritis international societyBioqube factory fundTechnology oganisation

ITM and ANSTO Announce Extension of Licensing Agreement for the Production and Supply of the Medical Radioisotope n c a Lutetium-177

Press release content from Business Wire. The AP news staff was not involved in its creation.

New zealandValeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonPhil mccallShaun jenkinsonAustralian nuclear scienceCorporate communicationsTechnology organisationTrophic communicationsTechnologies munichTargeted radionuclide therapyChief executive officerRadionuclide therapyActivity reference time

vimarsana © 2020. All Rights Reserved.